An ultrasensitive new DNA microarray chip provides gene expression profiles for preoperative esophageal cancer biopsies without RNA amplification

Oncology

Volumn 73, Issue 5-6, 2008, Pages 366-375

  Ito, Tetsuo ^a,b   Tanaka, Eiji ^b   Kadowaki, Tadashi ^b   Kan, Takatsugu ^a   Higashiyama, Motoshige ^b   Shiojima, Satoshi ^b   Tomoda, Shiori ^c   Myoumoto, Akira ^c   Akiyama, Hideo ^c   Nobumasa, Hitoshi ^c   Matsumoto, Shigemi ^b   Miyamoto, Shinichi ^b   Mitsumori, Michihide ^b   Sato, Fumiaki ^a   Watanabe, Go ^b   Itami, Atsushi ^b   Meltzer, Stephen J ^a   Tsujimoto, Gozoh ^b   Shimada, Yutaka ^b,d,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c TORAY INDUSTRIES INC   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e Department of Surgery and Science ^*  (Japan)

Author keywords

Biopsy; Diagnosis; Esophageal cancer; Microarray; Preoperative

Indexed keywords

RIBONUCLEOTIDE REDUCTASE; XRCC3 PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; GENE EXPRESSION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

AGED; BIOPSY; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREOPERATIVE CARE; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY;

EID: 45549102083     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000136156     Document Type: Article

References (22)

1. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(suppl 8):S4-S66.
2. Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux P, Van Raemdonck D: Cancer of the esophagus and gastro-esophageal junction: potentially curative therapies. Surg Oncol 2001;10:113-122.
3. Visbal AL, Allen MS, Miller DL, Deschamps C, Trastek VF, Pairolero PC: Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg 2001;71:1803-1808.
4. Sweet-Cordero A, Mukherjee S, Subramanian A, You H, Roix JJ, Ladd-Acosta C, Mesirov J, Golub TR, Jacks T: An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat Genet 2005;37:48-55.
5. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R: A geneexpression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
6. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson JA Jr, Marks JR, Dressman HK, West M, Nevins JR: Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006;439:353-357.
7. Iscove NN, Barbara M, Gu M, Gibson M, Modi C, Winegarden N: Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA. Nat Biotechnol 2002;20:940-943.
8. Puskas LG, Zvara A, Hackler L Jr, Van Hummelen P: RNA amplification results in reproducible microarray data with slight ratio bias. Biotechniques 2002;32:1330-1334, 1336, 1338, 1340.
9. Spiess AN, Mueller N, Ivell R: Amplified RNA degradation in T7-amplification methods results in biased microarray hybridizations. BMC Genomics 2003;4:44.
10. Nagino K, Nomura O, Takii Y, Myomoto A, Ichikawa M, Nakamura F, Higasa M, Akiyama H, Nobumasa H, Shiojima S, Tsujimoto G: Ultrasensitive DNA chip: gene expression profile analysis without RNA amplification. J Biochem (Tokyo) 2006;139:697-703.
11. Sobin L, Wittekind C: TNM Classification of Malignant Tumours, ed 6. New York, Wiley-Liss, 2002, pp 60-64.
12. Centeno BA, Enkemann SA, Coppola D, Huntsman S, Bloom G, Yeatman TJ: Classification of human tumors using gene expression profiles obtained after microarray analysis of fine-needle aspiration biopsy samples. Cancer 2005;105:101-109.
13. Braga-Neto UM, Dougherty ER: Is crossvalidation valid for small-sample microarray classification? Bioinformatics 2004;20:374-380.
14. Abraham JM, Wang S, Suzuki H, Jiang HY, Rosenblum-Vos LS, Yin J, Meltzer SJ: Esophagin cDNA cloning and characterization: a tissue-specific member of the small prolinerich protein family that is not expressed in esophageal tumors. Cell Growth Differ 1996;7:855-860.
15. Kimos MC, Wang S, Borkowski A, Yang GY, Yang CS, Perry K, Olaru A, Deacu E, Sterian A, Cottrell J, Papadimitriou J, Sisodia L, Selaru FM, Mori Y, Xu Y, Yin J, Abraham JM, Meltzer SJ: Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression. Int J Cancer 2004;111:415-417.
16. Smolinski KN, Abraham JM, Souza RF, Yin J, Wang S, Xu Y, Zou TT, Kong D, Fleisher AS, Meltzer SJ: Activation of the esophagin promoter during esophageal epithelial cell differentiation. Genomics 2002;79:875-880.
17. Kan T, Shimada Y, Sato F, Maeda M, Kawabe A, Kaganoi J, Itami A, Yamasaki S, Imamura M: Gene expression profiling in human esophageal cancers using cDNA microarray. Biochem Biophys Res Commun 2001;286:792-801.
18. Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
19. Kan T, Shimada Y, Sato F, Ito T, Kondo K, Watanabe G, Maeda M, Yamasaki S, Meltzer SJ, Imamura M: Prediction of lymph node metastasis with use of artificial neural networks based on gene expression profiles in esophageal squamous cell carcinoma. Ann Surg Oncol 2004;11:1070-1078.
20. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536.
21. Lin DW, Coleman IM, Hawley S, Dumpit R, Gifford D, Kezele P, Hung H, Knudsen BS, Kristal AR, Nelson PS: Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis. J Clin Oncol 2006;24:3763-3770.
22. Lin YM, Furukawa Y, Tsunoda T, Yue CT, Yang KC, Nakamura Y: Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 2002;21:4120-4128.